Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT05670028

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05670028
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05670028. Randomized; no masking; primary purpose treatment. Start 2023-06-04 (anticipated); primary completion 2026-01-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization
Acronym
RESCUE-CA
Condition
Revascularization
Condition
Blood Pressure
Condition
Cerebrovascular Insufficiency
Condition
Cerebral Autoregulation
Condition
Individuation
Condition
Hemorrhagic Transformation Due to Acute Stroke
Intervention (Drug)
Hypotensive Drugs and/or Vasoactive Drugs
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct05670028
Content hash
d943623c5f1d480d2f5752fc1448357b1aa31bde19e563ff6068e5bde8957a52